Revolution Medicines, Inc. Warrant (RVMDW)
USD 0.04
(-0.5%)
USD 0.04
(-0.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -487.18 Million USD | -88.63% |
| 2022 | -258.27 Million USD | -37.38% |
| 2021 | -188 Million USD | -69.84% |
| 2020 | -110.69 Million USD | -104.54% |
| 2019 | -54.12 Million USD | -34.2% |
| 2018 | -40.32 Million USD | -29.55% |
| 2017 | -31.12 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -156.64 Million USD | -11.21% |
| 2024 Q1 | -140.85 Million USD | 21.74% |
| 2023 Q1 | -75.15 Million USD | -21.8% |
| 2023 Q3 | -123.24 Million USD | -13.28% |
| 2023 Q2 | -108.79 Million USD | -44.76% |
| 2023 FY | -487.18 Million USD | -88.63% |
| 2023 Q4 | -179.98 Million USD | -46.03% |
| 2022 Q1 | -62.08 Million USD | -7.14% |
| 2022 FY | -258.27 Million USD | -37.38% |
| 2022 Q4 | -75.15 Million USD | -21.8% |
| 2022 Q2 | -76.53 Million USD | -23.26% |
| 2022 Q3 | -61.7 Million USD | 19.37% |
| 2021 FY | -188 Million USD | -69.84% |
| 2021 Q4 | -57.94 Million USD | -9.52% |
| 2021 Q3 | -52.91 Million USD | 0.47% |
| 2021 Q2 | -53.16 Million USD | -19.37% |
| 2021 Q1 | -44.53 Million USD | -19.09% |
| 2020 Q2 | -27.55 Million USD | 1.55% |
| 2020 Q1 | -27.98 Million USD | -32.74% |
| 2020 FY | -110.69 Million USD | -104.54% |
| 2020 Q4 | -37.39 Million USD | -9.73% |
| 2020 Q3 | -34.08 Million USD | -23.7% |
| 2019 Q4 | -21.08 Million USD | -7.76% |
| 2019 FY | -54.12 Million USD | -34.2% |
| 2019 Q3 | -19.56 Million USD | -44.29% |
| 2019 Q2 | -13.55 Million USD | -28.39% |
| 2019 Q1 | -10.56 Million USD | -1.2% |
| 2018 Q4 | -10.43 Million USD | 10.57% |
| 2018 Q3 | -11.66 Million USD | 0.0% |
| 2018 FY | -40.32 Million USD | -29.55% |
| 2017 FY | -31.12 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -105.384% |
| Alkermes plc | 414.12 Million USD | 217.643% |
| Agenus Inc. | -159.54 Million USD | -205.351% |
| Aptorum Group Limited | -10.52 Million USD | -4529.571% |
| Ardelyx, Inc. | -63.27 Million USD | -669.936% |
| Dyadic International, Inc. | -8.22 Million USD | -5819.811% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -40771.225% |
| Lantern Pharma Inc. | -17.87 Million USD | -2625.119% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2325.038% |
| Novavax, Inc. | -566.51 Million USD | 14.003% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -567.569% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -492.711% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2408.868% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4512.184% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -817.03% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -28.039% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1904.331% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1186.501% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -277.698% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -480.577% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2677.724% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1006.987% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1860.976% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -250.415% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -72.653% |
| AlloVir, Inc. | -181.33 Million USD | -168.672% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -137.649% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1565.134% |
| Bicycle Therapeutics plc | -189.94 Million USD | -156.486% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -183.607% |
| ChromaDex Corporation | -5.59 Million USD | -8601.286% |
| Chimerix, Inc. | -93.06 Million USD | -423.489% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -980.777% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -319.774% |
| CRISPR Therapeutics AG | -222.53 Million USD | -118.922% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1013.922% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -155.725% |
| Fortress Biotech, Inc. | -142.34 Million USD | -242.264% |
| Fortress Biotech, Inc. | -142.34 Million USD | -242.264% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -398.685% |
| ImmuCell Corporation | -5.74 Million USD | -8375.616% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -262.411% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2918.286% |
| Incyte Corporation | 620.52 Million USD | 178.512% |
| Innoviva, Inc. | 176.7 Million USD | 375.699% |
| IO Biotech, Inc. | -91.44 Million USD | -432.775% |
| Jaguar Health, Inc. | -34.29 Million USD | -1320.737% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -186.679% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4179.593% |
| ContextLogic Inc. | -328 Million USD | -48.532% |
| MiMedx Group, Inc. | 37.11 Million USD | 1412.601% |
| MEI Pharma, Inc. | 14.54 Million USD | 3450.193% |
| NextCure, Inc. | -67.63 Million USD | -620.294% |
| Onconetix, Inc. | -36.03 Million USD | -1251.992% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1067.917% |
| Opthea Limited | -191.84 Million USD | -153.95% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -17604.069% |
| Vaxcyte, Inc. | -468.04 Million USD | -4.09% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1031.798% |
| Precigen, Inc. | -88.92 Million USD | -447.873% |
| Pharming Group N.V. | -4.87 Million USD | -9884.232% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -191.184% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1537.266% |
| PureTech Health plc | -146.19 Million USD | -233.234% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2277.556% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -106.787% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1904.331% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -77.801% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1562.464% |
| Acelyrin, Inc. | -422.06 Million USD | -15.429% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3778009.863% |
| Summit Therapeutics Inc. | -89.73 Million USD | -442.909% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1214.443% |
| Senti Biosciences, Inc. | -92.72 Million USD | -425.397% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -324.477% |
| Elevation Oncology, Inc. | -45.44 Million USD | -972.032% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1321.732% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -12258.678% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -15307.495% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1375.379% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5630.914% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -616.491% |
| Seer, Inc. | -103.46 Million USD | -370.878% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -640.864% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -577.276% |
| ESSA Pharma Inc. | -32.13 Million USD | -1416.1% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1140.436% |
| GT Biopharma, Inc. | -13.57 Million USD | -3488.575% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -122.235% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -953.236% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 661.195% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -758.34% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -845.88% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4802.419% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 3.397% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -6962.699% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -861.05% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -87.625% |
| Aptose Biosciences Inc. | -52.35 Million USD | -830.524% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3278.355% |
| Soligenix, Inc. | -7.69 Million USD | -6228.771% |
| Century Therapeutics, Inc. | -146.54 Million USD | -232.445% |
| Kura Oncology, Inc. | -165.8 Million USD | -193.832% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -421.288% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5756.293% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -19531.582% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7413.649% |
| Autolus Therapeutics plc | -195.02 Million USD | -149.803% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -475.481% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -561.379% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2205.11% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -114.586% |
| GRI Bio, Inc. | -11.38 Million USD | -4178.432% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10688.657% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -271.35% |
| IGM Biosciences, Inc. | -263.46 Million USD | -84.917% |
| INmune Bio, Inc. | -29.74 Million USD | -1538.092% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -340.433% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1179.53% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2948.839% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2989.153% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -697.383% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -353.103% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -76.512% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -139.758% |
| Verastem, Inc. | -92.08 Million USD | -429.066% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -933.595% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -164.566% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -311.543% |
| Histogen Inc. | -10.64 Million USD | -4477.516% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3048.825% |
| Surrozen, Inc. | -45.78 Million USD | -964.187% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3129.385% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9470.971% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -721.817% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -849.789% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1827.156% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6282.746% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -184.433% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -905.584% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -522.959% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3100.79% |
| Apollomics, Inc. | -54.83 Million USD | -788.472% |
| Amarin Corporation plc | -67.58 Million USD | -620.816% |
| Mesoblast Limited | -58.79 Million USD | -728.63% |
| Turnstone Biologics Corp. | -59.03 Million USD | -725.29% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -194.318% |
| Synaptogenix, Inc. | -8.31 Million USD | -5759.918% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3240.086% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -431.334% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10067.765% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5416.612% |
| Exelixis, Inc. | 170.88 Million USD | 385.095% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1173.287% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -214.185% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 5.789% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4026.217% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5958.079% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1524.329% |
| Gritstone bio, Inc. | -154.63 Million USD | -215.057% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -607.49% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2745.2% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2508.336% |
| Insmed Incorporated | -709.62 Million USD | 31.346% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3005.109% |
| MediWound Ltd. | -15.29 Million USD | -3086.298% |
| OmniAb, Inc. | -69.41 Million USD | -601.804% |
| Alector, Inc. | -151.74 Million USD | -221.066% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -351.168% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -834.235% |
| Zai Lab Limited | -366.57 Million USD | -32.903% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -53.794% |
| Aura Biosciences, Inc. | -84.99 Million USD | -473.22% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -98.447% |
| Immunic, Inc. | -99.22 Million USD | -391.0% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -240.313% |
| Veracyte, Inc. | -85.79 Million USD | -467.848% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -72.874% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3328.466% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6973.007% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2492.428% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 184.204% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1814.057% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1355.567% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2461.193% |
| Galecto, Inc. | -39.9 Million USD | -1120.862% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1057.924% |
| Fortrea Holdings Inc. | 63.1 Million USD | 872.084% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -246.887% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1587.046% |
| XBiotech Inc. | -37.51 Million USD | -1198.814% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -607.49% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -625.842% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -351.49% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1797.729% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -814.18% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 14.41% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -520.681% |
| Vaxxinity, Inc. | -58.28 Million USD | -735.867% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -369.762% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2089.287% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -463.767% |
| NexImmune, Inc. | -29.19 Million USD | -1568.872% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8568.569% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3241.145% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.038% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1813.606% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4058.686% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -283.423% |
| Ainos, Inc. | -13.2 Million USD | -3589.008% |
| Pluri Inc. | -22.15 Million USD | -2098.687% |
| Prothena Corporation plc | -191.03 Million USD | -155.023% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -252.935% |
| Celularity Inc. | -192.28 Million USD | -153.363% |
| Rallybio Corporation | -78.93 Million USD | -517.221% |
| Cue Biopharma, Inc. | -52.14 Million USD | -834.217% |
| MeiraGTx Holdings plc | -137.06 Million USD | -255.451% |
| Omeros Corporation | -164.53 Million USD | -196.107% |
| Humacyte, Inc. | -100.04 Million USD | -386.956% |
| Immunocore Holdings plc | -59.64 Million USD | -716.753% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2525.061% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1889.891% |
| Blueprint Medicines Corporation | -486.27 Million USD | -0.187% |
| CalciMedica, Inc. | -21.87 Million USD | -2127.131% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -552.538% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -270.525% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -184.413% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -49.032% |
| Pulmatrix, Inc. | -14.74 Million USD | -3205.19% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1262.946% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -448.224% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 5.454% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -621.211% |
| Cytokinetics, Incorporated | -496.2 Million USD | 1.818% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1315.454% |
| Nutriband Inc. | -4.87 Million USD | -9899.844% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1017.064% |
| Vor Biopharma Inc. | -126.03 Million USD | -286.544% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 111.485% |
| Evogene Ltd. | -26.39 Million USD | -1746.027% |
| ProKidney Corp. | -151.52 Million USD | -221.528% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -654.916% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6233.459% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 19.788% |
| CorMedix Inc. | -48.95 Million USD | -895.112% |
| BioLineRx Ltd. | -49.69 Million USD | -880.37% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -326.708% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1179.641% |
| Atai Life Sciences N.V. | -125.47 Million USD | -288.285% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -496.753% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -498.441% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -95.666% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1484.857% |
| MediciNova, Inc. | -9.9 Million USD | -4820.929% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -285.514% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6626.79% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1721.733% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -110.152% |
| Biomea Fusion, Inc. | -126.13 Million USD | -286.241% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -39.434% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1614.474% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -154.952% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -111.862% |
| Absci Corporation | -115.51 Million USD | -321.75% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1665.995% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -331.645% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -101.181% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1833.581% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -134.23% |
| Allakos Inc. | -196.05 Million USD | -148.493% |
| Imunon, Inc. | -21.03 Million USD | -2216.572% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -340.238% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 554.116% |
| BioAtla, Inc. | -129.68 Million USD | -275.662% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4026.217% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2975.08% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -48.651% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1066.687% |
| XOMA Corporation | -41.84 Million USD | -1064.177% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -362.941% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -300.992% |
| aTyr Pharma, Inc. | -54.91 Million USD | -787.097% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -457.248% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -181.822% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -91.466% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2169.566% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5832.053% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2798.875% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5509154.181% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 244.319% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7356.127% |
| UroGen Pharma Ltd. | -65.53 Million USD | -643.385% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -445.694% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6607.754% |
| Orgenesis Inc. | -53.63 Million USD | -808.317% |
| Entera Bio Ltd. | -8.89 Million USD | -5379.53% |
| GH Research PLC | -41.22 Million USD | -1081.857% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1795.072% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -486.595% |
| Xencor, Inc. | -138.63 Million USD | -251.405% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9351.492% |
| Replimune Group, Inc. | -234.77 Million USD | -107.513% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2166.913% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3391.865% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7356.127% |
| Portage Biotech Inc. | -18.25 Million USD | -2569.068% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6626.79% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -364.158% |
| OncoCyte Corporation | -25.13 Million USD | -1838.196% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4209.519% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4152.269% |
| Purple Biotech Ltd. | 22.27 Million USD | 2287.531% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6385.423% |
| scPharmaceuticals Inc. | -55.39 Million USD | -779.459% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2478.013% |
| HilleVax, Inc. | -133.34 Million USD | -265.357% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3943.365% |
| Tharimmune, Inc. | -9.45 Million USD | -5052.551% |
| Genprex, Inc. | -31.07 Million USD | -1467.743% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -158.874% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1452.682% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -63584.314% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -8844.231% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3093191.123% |
| Savara Inc. | -60 Million USD | -711.88% |
| Curis, Inc. | -48.33 Million USD | -907.997% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1479.724% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9237.912% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6594.861% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1687.835% |
| BeiGene, Ltd. | -1.2 Billion USD | 59.661% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2343.341% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -420.208% |
| Erasca, Inc. | -141.52 Million USD | -244.24% |
| bluebird bio, Inc. | -244.26 Million USD | -99.452% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10661.825% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 350.557% |
| DBV Technologies S.A. | -76.43 Million USD | -537.41% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10661.825% |
| Moderna, Inc. | -4.23 Billion USD | 88.507% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1043.385% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7560.142% |
| Molecular Templates, Inc. | -10.46 Million USD | -4554.93% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -624.579% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -29.315% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -239.949% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -837.02% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -215.244% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -134.077% |
| MacroGenics, Inc. | -168.24 Million USD | -189.571% |
| RenovoRx, Inc. | -11.39 Million USD | -4175.053% |
| Adicet Bio, Inc. | -152.03 Million USD | -220.436% |
| Prime Medicine, Inc. | -191.29 Million USD | -154.681% |
| Aditxt, Inc. | -26.06 Million USD | -1769.3% |
| Adagene Inc. | -23.71 Million USD | -1953.911% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6564.548% |
| Quantum-Si incorporated | -111.17 Million USD | -338.23% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1439.386% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3241.973% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 499.286% |
| SciSparc Ltd. | -5.77 Million USD | -8339.027% |
| Vericel Corporation | -6.46 Million USD | -7436.897% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5527.861% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2007.24% |
| Generation Bio Co. | -138.56 Million USD | -251.598% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -486.758% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -463.48% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -102.067% |
| Invivyd, Inc. | -207.78 Million USD | -134.468% |
| Relay Therapeutics, Inc. | -373 Million USD | -30.613% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5094.698% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2367.981% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4635.929% |
| 2seventy bio, Inc. | -216.7 Million USD | -124.817% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2352.15% |
| Clene Inc. | -40.54 Million USD | -1101.739% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1923.373% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -789.089% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1721.733% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -39.172% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1226.322% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3130.323% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -369.793% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1332.813% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -186.112% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 28.806% |
| Evaxion Biotech A/S | -22.19 Million USD | -2094.824% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -491.373% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -118.347% |
| Trevena, Inc. | -35.28 Million USD | -1280.597% |
| Surrozen, Inc. | -45.78 Million USD | -964.187% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -509.4% |
| Cingulate Inc. | -22.75 Million USD | -2040.608% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6602.736% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -990.705% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5816.79% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -375.034% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -563.93% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -684.846% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5473.338% |
| Kronos Bio, Inc. | -121.83 Million USD | -299.889% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -539.384% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16510.552% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -383.189% |
| Statera Biopharma, Inc. | -98.34 Million USD | -395.39% |
| ImmunityBio, Inc. | -362.25 Million USD | -34.489% |
| Korro Bio, Inc. | -84.53 Million USD | -476.318% |
| Kineta, Inc. | -15.72 Million USD | -2998.55% |
| BioVie Inc. | -32.17 Million USD | -1413.957% |
| Codexis, Inc. | -68.06 Million USD | -615.722% |
| Celularity Inc. | -192.28 Million USD | -153.363% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -118.853% |
| Celcuity Inc. | -66.23 Million USD | -635.592% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7399.223% |
| Cibus, Inc. | -318.88 Million USD | -52.779% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1032.988% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1339.502% |
| IN8bio, Inc. | -30.33 Million USD | -1505.91% |
| Kodiak Sciences Inc. | -277.32 Million USD | -75.675% |
| Annexon, Inc. | -143.72 Million USD | -238.975% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -293.554% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -653.62% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1978.08% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -37.728% |
| Eyenovia, Inc. | -25.4 Million USD | -1817.565% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1592.601% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8659.169% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -515.653% |
| Arcellx, Inc. | -89.88 Million USD | -442.039% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -972.811% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -255.073% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1466.058% |
| Moolec Science SA | -6.65 Million USD | -7221.901% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -696.861% |
| Geron Corporation | -193.94 Million USD | -151.199% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1026.361% |
| Royalty Pharma plc | 1.49 Billion USD | 132.65% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -196.771% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5122.899% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2125.131% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -184.975% |
| Humacyte, Inc. | -100.04 Million USD | -386.956% |
| Structure Therapeutics Inc. | -102.77 Million USD | -374.031% |
| 89bio, Inc. | -151.2 Million USD | -222.204% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -507.978% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3250.653% |
| Genelux Corporation | -24.16 Million USD | -1916.077% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1336.15% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -183.659% |
| Notable Labs, Ltd. | -14.65 Million USD | -3223.907% |
| Liquidia Corporation | -73.38 Million USD | -563.884% |
| Mustang Bio, Inc. | -50.72 Million USD | -860.425% |
| Immunovant, Inc. | -282.7 Million USD | -72.327% |
| Quantum-Si incorporated | -111.17 Million USD | -338.23% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -523.772% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2190.803% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -377.576% |
| Acasti Pharma Inc. | -11.31 Million USD | -4206.798% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2025.487% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2948.839% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -127.599% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13178.153% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2966.757% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1570.902% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1077.23% |
| PepGen Inc. | -84.76 Million USD | -474.741% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1544.173% |
| United Therapeutics Corporation | 1.18 Billion USD | 141.116% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2027.724% |
| Solid Biosciences Inc. | -104.31 Million USD | -367.033% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1384.953% |
| Immuneering Corporation | -58.41 Million USD | -734.037% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9470.971% |
| Silo Pharma, Inc. | -3.85 Million USD | -12535.803% |
| Belite Bio, Inc | -31.66 Million USD | -1438.414% |
| XOMA Corporation | -41.84 Million USD | -1064.177% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -621.542% |
| Bionomics Limited | -17.89 Billion USD | 97.277% |
| Apogee Therapeutics, Inc. | -93 Million USD | -423.838% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1465.429% |
| uniQure N.V. | -282.87 Million USD | -72.229% |
| Cassava Sciences, Inc. | -105.95 Million USD | -359.795% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6564.548% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -276.193% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1399.677% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5763.514% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1557.374% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8659.169% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3328.466% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5380.763% |
| Altimmune, Inc. | -95.92 Million USD | -407.86% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -562.891% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1465.429% |
| Compugen Ltd. | -12.99 Million USD | -3649.885% |
| Peak Bio, Inc. | -1356.23 USD | -35921904.38% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -882.149% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2066.229% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -101.064% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1537.817% |
| Zura Bio Limited | -62.63 Million USD | -677.779% |
| PolyPid Ltd. | -22.86 Million USD | -2030.516% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2893.272% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1537.817% |
| Instil Bio, Inc. | -159.16 Million USD | -206.08% |
| argenx SE | -425.04 Million USD | -14.619% |
| Immunome, Inc. | -109.53 Million USD | -344.796% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -867.347% |
| Verona Pharma plc | -67.83 Million USD | -618.235% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1769.474% |
| Shattuck Labs, Inc. | -91.95 Million USD | -429.797% |
| CervoMed Inc. | -7.81 Million USD | -6135.653% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -566.373% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3557.27% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -911.303% |
| Moolec Science SA | -6.65 Million USD | -7221.901% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2861.892% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -260.273% |
| AnaptysBio, Inc. | -164.41 Million USD | -196.321% |
| Design Therapeutics, Inc. | -78.19 Million USD | -523.078% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -459.719% |
| NeurAxis, Inc. | -6.66 Million USD | -7210.156% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1102.956% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1230.598% |
| Achilles Therapeutics plc | -75.25 Million USD | -547.379% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1769.474% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3514.802% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 9548.325% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16510.552% |
| Nutriband Inc. | -4.87 Million USD | -9899.844% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -339.777% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -778.618% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -858.346% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -637.054% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -800.143% |
| Palisade Bio, Inc. | -13.07 Million USD | -3627.506% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -972.882% |
| Beam Therapeutics Inc. | -176.48 Million USD | -176.049% |
| Neurogene Inc. | -55.58 Million USD | -776.5% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -346.328% |
| AEON Biopharma, Inc. | -48.42 Million USD | -905.978% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -403.759% |
| Sesen Bio, Inc. | -25.9 Million USD | -1780.37% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -483.253% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3770.573% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -5.781% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -572.545% |
| Athira Pharma, Inc. | -125.46 Million USD | -288.3% |
| Vaccinex, Inc. | -22.88 Million USD | -2028.84% |
| HCW Biologics Inc. | -25.71 Million USD | -1794.397% |
| XOMA Corporation | -41.84 Million USD | -1064.177% |
| Nektar Therapeutics | -137.42 Million USD | -254.51% |
| Arvinas, Inc. | -401.5 Million USD | -21.341% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5509154.181% |
| Merus N.V. | -156.54 Million USD | -211.207% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -385.917% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1307.236% |
| Rezolute, Inc. | -70.42 Million USD | -591.798% |
| Clene Inc. | -40.54 Million USD | -1101.739% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2874.545% |
| BeyondSpring Inc. | -23.11 Million USD | -2007.749% |
| Synlogic, Inc. | -55.16 Million USD | -783.206% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2617.302% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4400.97% |
| Peak Bio, Inc. | -1356.23 USD | -35921904.38% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1102.837% |
| Krystal Biotech, Inc. | -109.72 Million USD | -343.997% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -276.088% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -42.031% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10165.272% |
| MannKind Corporation | 8.67 Million USD | 5714.024% |
| Ikena Oncology, Inc. | -75.41 Million USD | -545.988% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4950.119% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -624.654% |
| Gossamer Bio, Inc. | -183.75 Million USD | -165.122% |
| CohBar, Inc. | -12.38 Million USD | -3832.623% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -860.463% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1665.995% |
| Legend Biotech Corporation | -439.48 Million USD | -10.854% |
| Mural Oncology plc | -194.63 Million USD | -150.303% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -625.593% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2917.509% |
| Disc Medicine, Inc. | -91.12 Million USD | -434.634% |
| Champions Oncology, Inc. | -7.35 Million USD | -6522.961% |
| REGENXBIO Inc. | -268.12 Million USD | -81.699% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4445.405% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -773.78% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1150.454% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -326.021% |
| Vaxart, Inc. | -83.34 Million USD | -484.526% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5618.128% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1038.44% |
| Cellectis S.A. | -106.62 Million USD | -356.91% |
| Longeveron Inc. | -21.02 Million USD | -2216.729% |
| Repare Therapeutics Inc. | -116.22 Million USD | -319.178% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -81.905% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -544.041% |
| Revolution Medicines, Inc. | -487.18 Million USD | -0.0% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7223.888% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1008.397% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -553.151% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -599.627% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4324.53% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 111.31% |
| Denali Therapeutics Inc. | -196.69 Million USD | -147.68% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5527.861% |
| Veru Inc. | -93.78 Million USD | -419.485% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1988.324% |
| Cingulate Inc. | -22.75 Million USD | -2040.608% |
| Passage Bio, Inc. | -108.38 Million USD | -349.478% |
| Context Therapeutics Inc. | -25.07 Million USD | -1843.096% |
| Exicure, Inc. | -14.99 Million USD | -3148.766% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -136.424% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1100.022% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4913.771% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -164.262% |
| Nuvalent, Inc. | -149.49 Million USD | -225.894% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5829.343% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -449.058% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2245.167% |
| OmniAb, Inc. | -69.41 Million USD | -601.804% |
| Anew Medical, Inc. | -1.3 Million USD | -37351.57% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3714.776% |
| Lipocine Inc. | -17.93 Million USD | -2617.005% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -611.084% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -539.753% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1179.53% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1132.537% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2076.488% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 15.981% |
| Ocugen, Inc. | -65.53 Million USD | -643.442% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -419.022% |
| Q32 Bio Inc. | -92.1 Million USD | -428.962% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2172.424% |
| Alumis Inc. Common Stock | -158.17 Million USD | -208.006% |
| Equillium, Inc. | -14.52 Million USD | -3254.807% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -680.67% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6064.286% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2482.466% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -937.646% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -349.159% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3970.045% |
| Dominari Holdings Inc. | -21.79 Million USD | -2135.204% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5182.422% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1810.38% |
| Bio-Techne Corporation | 206.68 Million USD | 335.713% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -24.445% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 353.703% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -268.307% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1169.008% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -222.423% |
| Nkarta, Inc. | -131.65 Million USD | -270.061% |
| BioCardia, Inc. | -11.64 Million USD | -4084.0% |
| Iterum Therapeutics plc | -47.46 Million USD | -926.344% |